Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Intensive Versus Guideline Antiplatelet Therapy in High Risk Patients With Recent Ischaemic Stroke or Transient Ischaemic Attack: a Randomised Controlled Trial

NCT01661322 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT01661322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Intensive Versus Guideline Antiplatelet Therapy in High Risk Patients With Recent Ischaemic Stroke or Transient Ischaemic Attack: a Randomised Controlled Trial
Lead sponsor
University of Nottingham
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2009
Completion date
September 30, 2017
Enrollment
3,096 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke